
### [MONDO:0020140](http://purl.obolibrary.org/obo/MONDO_0020140)
**Label:** late-onset ataxia with dementia

**Subclasses:** [MONDO:0020380](http://purl.obolibrary.org/obo/MONDO_0020380) (autosomal dominant cerebellar ataxia), [MONDO:0011694](http://purl.obolibrary.org/obo/MONDO_0011694) (spinocerebellar ataxia type 15/16), [MONDO:0019793](http://purl.obolibrary.org/obo/MONDO_0019793) (autosomal dominant cerebellar ataxia type 3), [MONDO:0019794](http://purl.obolibrary.org/obo/MONDO_0019794) (autosomal dominant cerebellar ataxia type 4), [MONDO:0016163](http://purl.obolibrary.org/obo/MONDO_0016163) (autosomal dominant cerebellar ataxia type 2), [MONDO:0019792](http://purl.obolibrary.org/obo/MONDO_0019792) (autosomal dominant cerebellar ataxia type i), [MONDO:0008458](http://purl.obolibrary.org/obo/MONDO_0008458) (spinocerebellar ataxia type 2), [MONDO:0007182](http://purl.obolibrary.org/obo/MONDO_0007182) (Machado-Joseph disease), 

**Corr. equiv. classes:** [Orphanet:99](http://www.orpha.net/ORDO/Orphanet_99), [OMIM:606658](http://purl.obolibrary.org/obo/OMIM_606658), [OMIM:109150](http://purl.obolibrary.org/obo/OMIM_109150), [Orphanet:98756](http://www.orpha.net/ORDO/Orphanet_98756), [Orphanet:94145](http://www.orpha.net/ORDO/Orphanet_94145), [Orphanet:98757](http://www.orpha.net/ORDO/Orphanet_98757), [Orphanet:208508](http://www.orpha.net/ORDO/Orphanet_208508), [Orphanet:94148](http://www.orpha.net/ORDO/Orphanet_94148), [Orphanet:94149](http://www.orpha.net/ORDO/Orphanet_94149), [OMIM:183090](http://purl.obolibrary.org/obo/OMIM_183090), 

**Class expressions from DL-Learner:**

- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 65.00%
- [HP:0000602](http://purl.obolibrary.org/obo/HP_0000602) (Ophthalmoplegia) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 65.00%


